Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple electrical patch help seniors regain leg strength?

NCT ID NCT07668258

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a home-use electrical stimulation device can safely improve leg muscle strength and physical performance in 40 older adults with sarcopenia (age-related muscle loss). Participants use the device on their thighs for 20 minutes, at least 4 times a week, for 8 weeks. The trial is double-blind and sham-controlled, meaning some will get a placebo device, to see if the real device truly helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
neuromuscular electrical stimulation (NMES) device
What this could lead to
If it works, this could provide a simple, home-based way to help older adults with sarcopenia regain leg strength and mobility.
What could go wrong
This is a small, early exploratory trial with only 40 participants. The sham control may reveal no benefit, and results may not apply to all people with sarcopenia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosed with sarcopenia according to the Asian Working Group for Sarcopenia (2019) criteria 2. Able to perform the exercise program provided by the investigators, with sufficient physical and cognitive function 3. Able to understand the study explanation and provide voluntary informed consent 4. Able to operate a mobile phone independently or with assistance from a caregiver Exclusion Criteria: 1\) History of Knee Surgery * Any prior surgical procedure on either knee (right or left) 2) Recent Knee Injection or Procedure * Receipt of any injection or interventional procedure in either knee within the past 3 months 3) Ongoing Treatment for Knee Pain * Currently receiving medication or physical therapy for knee pain 4) Implanted Electrical Devices * Presence of an implanted electrical device (e.g., pacemaker, electrical stimulator) 5) Seizure Disorder * Current or past history of seizures requiring medication 6) Severe Peripheral Arterial Disease * Significant arterial circulatory disorder in the lower extremities 7) Hernia * Presence of abdominal or inguinal hernia 8) Difficulty Operating Devices * Difficulty operating medical devices or mobile phones 9) Metal Allergy * Known metal allergy that interferes with device application 10) Skin Lesions on Thigh * Skin conditions on the thigh (e.g., burns, scars) that interfere with electrical stimulation 11) Suspected Infection on Thigh * Signs suggestive of infection on the thigh (e.g., erythema, warmth) 12) Impaired Sensation at Patch Site * Reduced sensation at the patch site preventing adequate self-reporting 13) End-stage Organ Failure * Diagnosis of end-stage heart failure or end-stage renal disease requiring dialysis 14) Abnormal Laboratory Findings * Any of the following (based on the most recent test within 6 months; if unavailable, a screening CBC will be performed): * Platelet count \< 50,000/μL * Hemoglobin \< 8.0 g/dL * Absolute neutrophil count \< 1,000/μL 15) Impaired Ambulation * Difficulty walking due to visual impairment, fracture, severe muscle paralysis, dizziness, or other causes 16) Inability to Participate in Rehabilitation Exercise * Judged by the investigator as unable to participate in rehabilitation exercise For example, diagnosis of Cachexia, defined as: Unintentional weight loss ≥ 5% within the past 6 months, or BMI \< 20 kg/m² with ≥ 2% weight loss 17) Withdrawal or Lack of Consent 18) Other Reasons * Any other condition deemed by the investigator to make the participant unsuitable for participation in this clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sarcopenia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.